Pelvital Raises $2.68M in Seed Funding

Source: FinSMEs Pelvital secures $2.68M in seed funding to advance its innovative solutions for pelvic health. This investment will accelerate product development and expand market reach for their cutting-edge medical devices.

Pelvital, an Eagan, MN-based women’s health company, closed a $2.68m seed funding round.

The round was led by Boomerang Ventures, with participation from VisionTech Partners, Wisconsin Investment Partners, and Edward Bergmark, PhD, Founder and former CEO of Optum.

Led by Lydia Zeller, President and CEO, Pelvitan is advancing Flyte, an FDA-cleared treatment for stress urinary incontinence (SUI) and weakened pelvic floor muscles. It is an at-home intravaginal device that delivers the proven treatment modality of mechanotherapy to treat SUI and strengthen pelvic floor muscles quickly and effectively.

Read full article >